Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study.
Supplementing cross-cover communication with the patient acuity rating.
Transplantation tolerance: don't forget about the B cells.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Transplantation tolerance: don't forget about the B cells.
Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
View in:
PubMed
subject areas
Animals
Biomarkers
B-Lymphocytes, Regulatory
Clonal Anergy
Graft Rejection
Graft Survival
Humans
Interleukin-10
Lymphocyte Activation
Mice
T-Lymphocytes, Regulatory
Transplantation Tolerance
authors with profiles
Anita S. Chong